PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-698

5 cohort 1 patient as 22 Oct 2023 announcement used

As of 3 July 2024
Patient A - 377 days diagnosed prior to mpl and on mpl for 510 days total 887 days since diagnosed

Patient B - 323 days diagnosed prior to mpl and on mpl for 520 days total 843 days since diagnosed

Patient C - 480 days diagnosed prior to mpl and on mpl for 480 days total 960 days since diagnosed

Patient D - 668 days diagnosed prior to mpl and on mpl 520 days total 1188 days since diagnosed

Patient E - 432 days diagnosed prior to mpl and on mpl 514 days total 946 days since diagnosed